Bâloise Holding (BALN) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
8 Jul, 2026Executive summary
Refocusing strategy launched in September 2024 delivered strong underlying results, higher profitability across all business units, and significant improvement in core business.
Profit attributable to shareholders rose 60.6% year-over-year to CHF 385 million, despite a CHF 92 million negative impact from the sale of FRIDAY and discontinuation of the ecosystem strategy.
Cash remittance grew to CHF 565 million, supporting increased shareholder payouts via a higher dividend and a planned CHF 100 million share buyback.
All countries increased their EBIT contribution, with Switzerland showing the largest improvement.
Dividend per share proposed at CHF 8.10, up CHF 0.40, with a CHF 100 million share buyback planned.
Financial highlights
EBIT increased 58.3% year-over-year to CHF 545 million; non-life EBIT up 94.9% to CHF 261 million, life EBIT up 39% to CHF 282 million.
Return on equity rose from 7.2% to 13.9%, within the 12%-15% target range.
Combined ratio improved by 1.7 percentage points to 92.9%, within guidance, despite major storm events.
Cash remittance reached CHF 565 million, including a CHF 62 million non-recurring gain from Belgium life back book optimization.
Non-life premiums grew by 2.2% in local currency to CHF 4,120 million; investment-type premiums up 20.2% to CHF 1,048 million; life premiums declined by 5.2%.
Outlook and guidance
Targeting a combined ratio of about 90% by 2027, with expense ratio aimed at a maximum of 26%-28%.
Cash remittance goal of more than CHF 2 billion for 2024–2027 period.
Dividend proposed at CHF 8.10 per share, with a CHF 100 million share buyback planned.
Total cash payout ratio increased to 83%, exceeding the 80% strategic target.
Guidance for life EBIT remains at least CHF 200 million, with CSM release ratio at a sustainable 5.4%.
Latest events from Bâloise Holding
- Merger forms a Swiss insurance leader with CHF 350M synergies and 20% dividend uplift by 2029.BALN
M&A Announcement8 Jul 2026 - Merger creates Switzerland's largest insurer, with synergy targets and stable fundamentals.BALN
Status Update8 Jul 2026 - Profit up 25.5% to CHF 275.9m; combined ratio at 90.6%; Helvetia merger on track.BALN
H1 20258 Jul 2026 - Shareholder profit up 6.9% to CHF 220m; new strategy, strong capital, and payout targets.BALN
H1 2024 & Investor Update20 Jan 2026 - Refocusing strategy advances with strong cash remittance and resilient non-life growth.BALN
Q3 2024 TU13 Jun 2025